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Abstract
Objective and design Oxygen tension and biomechanical
signals are factors that regulate inflammatory mechanisms
in chondrocytes. We examined whether low oxygen ten-
sion influenced the cells response to TNFa and dynamic
compression.
Materials and methods Chondrocyte/agarose constructs
were treated with varying concentrations of TNFa
(0.1–100 ng/ml) and cultured at 5 and 21 % oxygen ten-
sion for 48 h. In separate experiments, constructs were
subjected to dynamic compression (15 %) and treated with
TNFa (10 ng/ml) and/or L-NIO (1 mM) at 5 and 21 %
oxygen tension using an ex vivo bioreactor for 48 h.
Markers for catabolic activity (NO, PGE2) and tissue
remodelling (GAG, MMPs) were quantified by biochemi-
cal assay. ADAMTS-5 and MMP-13 expression were
examined by real-time qPCR. 2-way ANOVA and a post
hoc Bonferroni-corrected t test were used to analyse data.
Results TNFa dose-dependently increased NO, PGE2 and
MMP activity (all p\ 0.001) and induced MMP-13
(p\ 0.05) and ADAMTS-5 gene expression (pp\ 0.01)
with values greater at 5 % oxygen tension than 21 %. The
induction of catabolic mediators by TNFa was reduced by
dynamic compression and/or L-NIO (all p\ 0.001), with a
greater inhibition observed at 5% than 21 %. The stimu-
lation of GAG synthesis by dynamic compression was
greater at 21 % than 5 % oxygen tension and this response
was reduced with TNFa or reversed with L-NIO.
Conclusions The present findings revealed that TNFa
increased production of NO, PGE2 and MMP activity at
5 % oxygen tension. The effects induced by TNFa were
reduced by dynamic compression and/or the NOS inhibitor,
linking both types of stimuli to reparative activities. Future
therapeutics should develop oxygen-sensitive antagonists
which are directed to interfering with the TNFa-induced
pathways.
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Osteoarthritis (OA) is a progressive joint disease typically
characterized by cartilage loss, joint pain and dysfunction. In
OA, chondrocytes produce greater levels of pro-inflamma-
tory cytokines such as interleukin 1b (IL-1b) and tumour
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necrosis factor alpha (TNFa) which increase breakdown of
the extracellular matrix [1–3]. Whilst IL-1b is the principal
cytokine known to drive breakdown of cartilage, TNFa will
also contribute to the pro-inflammatory process in chon-
drocytes [4–7]. There is also strong evidence that
biomechanical signals and oxygen tension will additionally
cross-talk with the pro-inflammatory process and activate
changes that influence tissue remodelling [8–13]. However,
little is known about the combined effects of oxygen tension
and TNFa on triggering the pro-inflammatory events and
how the pathways are regulated by biomechanical signals.
Several in vitro studies have demonstrated that treatment of
chondrocytes with TNFa increases production of nitric oxide
(NO), prostaglandin E2 (PGE2), matrix metalloproteinase
(MMP)-1, 3 and 13 and a disintegrin and metalloproteinase
with thrombospondin motifs (ADAMTS-5) in human, rabbit,
canine or bovine chondrocytes cultured inmonolayer, explant
or 3D alginate models [5–7, 14–22]. The effects induced by
TNFa were shown to be mediated by the mitogen activated
protein kinase (MAPK) family or nuclear factor-kappa B
(NFjb), leading to increased proteoglycan depletion and
expression of MMP-1, 3 and 13, NO and PGE2 [23–26]. The
NFjb transcription factor was reported to control the
expression of several cytokines orMMPenzymes [27, 28] and
its regulation by oxygen tension will influence the catabolic
effects of the cytokine [29–33]. In addition, oxygen tension
was reported to influence the production of NO and PGE2 in
response to biomechanical signals. For example in the chon-
drocyte/agarose model, low oxygen tension at 5 % enhanced
the production of NO and PGE2 release in constructs cultured
with IL-1b when compared to 21 % oxygen tension and this
response was abolished by dynamic compression [34].
However, the combined effect of TNFa and biomechanical
signals on the production of NO and PGE2 in chondrocytes at
5 % oxygen tension is not known. The present study therefore
examined whether low oxygen tension could influence the
response of chondrocytes to TNFa and dynamic compression
by comparing markers for catabolic activity (NO, PGE2) and
tissue remodelling (GAG, MMP-13, ADAMTS-5) at 5 and
21 % oxygen tension.
Materials and methods
Chondrocyte isolation and culture in agarose
constructs
Full depth slices of articular cartilage were isolated from
freshly slaughtered cattle aged\18 months (Dawn Card-
ington, Bedfordshire, UK), as previously described [35].
Cartilage tissue was pooled from two joints, diced and
incubated on rollers for 1 h at 37 C in Dulbecco’s modi-
fied Eagle’s medium supplemented with 20 % (v/v) foetal
calf serum (DMEM ? 20 % FCS), 2 lM L-glutamine,
5 lg ml penicillin, 5 lg/ml streptomycin, 20 mM Hepes
buffer, and 0.85 lM L-ascorbic acid ? 700 unit/ml pro-
nase, and for a further 16 h at 37 C in DMEM ? 20 %
FCS, supplemented with 100 unit/ml collagenase type XI
(Sigma Chemical Co., Poole, UK). The cell suspension was
washed and viable chondrocytes counted using a haemo-
cytometer and Trypan blue. Cells were resuspended in
medium at a cell concentration of 8 9 106 cells/ml. The
cell suspension was added to an equal volume of molten
6 % (w/v) agarose type VII (Sigma Chemical Co., Poole,
UK) in Earle’s Balanced Salt Solutions (EBSS, Sigma
Chemical Co., Poole, UK) to yield a final cell concentra-
tion of 4 9 106 cells/ml in 3 % (w/v) agarose. The
chondrocyte/agarose suspension was transferred into a
sterile stainless steel mould, containing holes 5 mm in
diameter and 5 mm in height and allowed to gel at 4 C for
10 min to yield cylindrical constructs. All constructs were
equilibrated in culture in 1 ml DMEM ? 20 % FCS at 5 or
21 % oxygen tension for 72 h.
Effect of oxygen tension and TNFa in chondrocyte/
agarose constructs
The effect of 5 and 21 % oxygen tension were examined in
constructs cultured under free-swelling conditions in a
glove-box style workspace integrated within a Biospherix
incubator to ensure that the experimental conditions during
setup and experimentation were uninterrupted, as previ-
ously described [34]. Constructs were cultured with TNFa
(Peprotech EC Ltd, London, UK) at concentrations ranging
from 0.1, 1, 10 and 100 ng/ml in the presence and absence
of 1 mM L-N-(1-iminoethyl)-ornithine (L-NIO) for up to
48 h. L-NIO inhibits all isoforms of the nitric oxide syn-
thase enzymes (Merck Chemicals, Nottingham, UK).
Application of dynamic compression
In separate experiments, a novel ex vivo bioreactor (Bose
ElectroForce, Gillingham, UK) was used to apply dynamic
compression to constructs cultured at 5 or 21 % oxygen
tension, as previously described [34]. Constructs were
transferred into individual wells of a 24-well culture plate
(Costar, High Wycombe, UK) and mounted within the
bioreactor system that is integrated within the Biospherix
incubator. The medium was supplemented with either 0 or
10 ng/ml TNFa in the presence and absence of 1 mM
L-NIO and the experimental conditions during setup and
culture were uninterrupted. Constructs were subjected to
intermittent compression under unconfined conditions,
with a profile of 10 min compression followed by a 5 h
50 min unstrained period for both the 6 and 48 h culture
periods, as previously described [34]. The ex vivo
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conditions were found to be optimal when measuring gene
expression and protein synthesis at these time points [34].
The compression regime was applied in a dynamic manner
with a strain amplitude of 0–15 % using a sinusoidal
waveform at a frequency of 1 Hz and resulted in duty
cycles which ranged from 600 to 4800 cycles for the 6 and
48 h culture periods, respectively. Control constructs were
maintained in an unstrained state in the bioreactor system
and cultured for the same time period. At the end of the
experiment, the constructs and corresponding media were
stored at -70 C prior to analysis.
Biochemical analysis
NO and PGE2 production were determined in supernatant by
Griess andEIA (GEHealthcare, Buckinghamshire,UK) using
well established methods [34, 35]. Total MMP activity was
measured in media samples using a fluorogenic substrate
assay. 25 ll samplewas incubatedwith 2.5 lMamino-phenyl
mercuric acetate (APMA) for 1 h at room temperature to
activate latent MMPs. Each sample was subsequently mixed
with an equal volume of 10 lM Dnp-PChaGCHAK(Nma)
fluorogenic MMP substrate, 50 ll buffer (500 mM HEPES,
100 mM CaCl2, 0.5 % Brij-35, pH 7.0) in a 96-well plate
(Enzo Life Sciences, Exeter, UK) and reactions measured at
excitation and emission values of 340 and 440 nm, respec-
tively. The change in fluorescencewas calculated in the linear
regionof the kinetic assay for each sample between a periodof
5 and 60 min at 37 C. GAG synthesis was measured in
constructs and media samples by DMMB assay and normal-
ized to DNA valuesmeasured using the Hoescht dye 33258 in
agarase/papain digests, as described [34, 35].
RNA extraction, cDNA synthesis and real-time
quantitative PCR
RNA was isolated from chondrocytes cultured in agarose
as previously described (Qiagen, West Sussex, UK)
[34, 36]. RNA was quantified on the Nanodrop ND-1000
spectrophotometer (LabTech, East Sussex, UK) and
reverse transcription was performed using the Enhanced
Avian RT First Strand cDNA synthesis kit, oligo(dT)23
primer, and a total of 200 ng of RNA (Sigma Genosys,
Cambridge, UK) according to the manufacturer’s proto-
cols. Real-time quantitative PCR were performed in 10 ll
reaction mixtures containing 2.5 ll cDNA, 5 ll Kapa
SYBR FAST Universal qPCR Master Mix (2X) (Kapa
Biosystems, Wilmington, Massachusetts, USA), primer
pairs at final concentrations of 0.5 lM and nuclease-free
PCR-grade water to 10 ll (Sigma Genosys, Cambridge,
UK). The following specific primer sequences were used:
ADAMTS-5 (NM_001166515) Forward: 50-GCCCTGCCC
AGCTAACGGTA-30, Reverse: 50-CCCCCGGACACACA
CGGAA-30, MMP-13 (NM_174389.2) Forward: 50-CCC
TTGATGCCATAACCAGT-30, Reverse 50-GCCCAAAAT
TTTCTGCCTCT-30 and 18S (NR_036642.1) Forward: 50-
GCAATTATTCCCCATGAACG-30, Reverse: 50-GGCCT
CACTAAACCATCCAA-30. Each sample was run in
duplicate on the 96-well thermal system of the Mx3000P
quantitative PCR instrument (Stratagene, Amsterdam, The
Netherlands). Thermocycling conditions comprised an initial
polymerase activation step at 95 C for 3 min, followed by
denaturation of 35 cycles at 95 C for 30 s, annealing at 55 C
for 1 min, and extension at 72 C for 1 min. Fluorescence
data were collected during the annealing stage of amplifica-
tion, and data were analysed on the MxPro qPCR software
(version 3, Stratagene). Baselines and thresholds were auto-
matically set by the RG-3000 qPCR software and used after
manual inspection. The cycle threshold (Ct) value for each
duplicate reaction was expressed as the mean value, and the
results were exported into Microsoft Excel for further analy-
sis. The data obtained by PCR assay for 18Swere validated as
a reference gene by displaying the Ct values as box-and-
whisker plots, and the distribution examined under the treat-
ment conditions (data not shown). The Ct values for 18S
remained stable, with no changes detected under all culture
conditions, suggesting its suitability as a reference gene.
Relative quantifications of ADAMTS-5 andMMP-13 signals
were estimated by normalizing each target to the reference
gene, 18S, and to the calibrator sample by a comparative Ct
approach. For each sample, the ratio of target DCt and refer-
ence DCt was calculated, as previously described [36, 37].
Ratios were expressed on a logarithmic scale (arbitrary units).
Statistics
For free-swelling studies, data represent the mean and SEM
values for 6–18 replicates from 3 to 4 separate experi-
ments. For the ex vivo bioreactor experiments, data
represent the mean and SEM values of 8–12 replicates
from two separate experiments. Statistical analysis was
performed by a two-way analysis of variance (ANOVA)
and the multiple post hoc Bonferroni-corrected t tests to
compare differences between the various treatment groups
as indicated in the figure legend. In all cases, a level of 5 %
was considered statistically significant (p\ 0.05).
Results
Low oxygen tension dose-dependently increased
production of catabolic mediators in chondrocytes
treated with TNFa
At 5 and 21 % oxygen tensions, the levels of NO were
enhanced by TNFa, with a significant increase at 1, 10 and
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100 ng/ml, when compared to untreated controls (all
p\ 0.001; Fig. 1a). The NOS inhibitor abolished cytokine-
induced NO release with levels returning to basal values at
both 5 and 21 % oxygen. At 10 and 100 ng/ml TNFa, the
levels of NO release were greater at 5 % oxygen tension
when compared to 21 % (both p\ 0.001). TNFa dose-
dependently increased PGE2 release with values greater at
5 % than 21 % oxygen tension (all p\ 0.001; Fig. 1b).
These effects were partially reversed with the NOS inhi-
bitor (all p\ 0.001). TNFa concentrations greater than
1 ng/ml increased MMP activity in a dose-dependent
manner at both oxygen tension when compared to
untreated controls (Fig. 1c). Co-incubation with the NOS
inhibitor partially reversed this effect in TNFa-treated
constructs cultured at either 5 or 21 % oxygen. At 10 and
100 ng/ml, MMP activity was significantly greater at 5 %
oxygen when compared to 21 % (all p\ 0.001).
Low oxygen tension dose-dependently influenced
matrix synthesis and loss in chondrocytes treated
with TNFa
In the absence of the cytokine, GAG synthesis was greater at
21 % oxygen when compared to 5 % (p\ 0.001; Fig. 2a).
At low cytokine concentration (0.1 ng/ml), TNFa did not
significantly influence GAG synthesis when compared to
untreated controls cultured at either 5 or 21 % oxygen
(Fig. 2a). At TNFa concentrations of 1–100 ng/ml, the
cytokine downregulated GAG synthesis (p\ 0.05) but the
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Fig. 1 Effect of 5 and 21 % oxygen tension in chondrocytes treated
with varying concentrations of TNFa. Chondrocyte/agarose con-
structs were cultured for 48 h with varying concentrations of TNFa
(0.1–100 ng/ml) and/or L-NIO (1 mM) and the effects of 5 and 21 %
oxygen tension were examined on NO release (a), PGE2 release
(b) and total MMP activity (c). Error bars represent the mean and
SEM values for 6–18 replicates from four separate experiments. ? or
??? indicates significant comparisons between untreated and
cytokine-treated constructs cultured at 21 % oxygen tension; $ or
$$$ indicates significant comparisons between untreated and
cytokine-treated constructs cultured at 5 % oxygen tension; ** or
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Fig. 2 Dose-dependent effects of TNFa on matrix synthesis and
degradation at 5 and 21 % oxygen tension. Chondrocyte/agarose
constructs were cultured with varying concentrations of TNFa
(0.1–100 ng/ml) and/or L-NIO (1 mM) for 48 h and the effects of 5
and 21 % oxygen tension were examined on GAG synthesis (a) and
GAG loss (b). Error bars represent the mean and SEM values for
6–18 replicates from four separate experiments. ? or ??? indicates
significant comparisons between untreated and cytokine treated
constructs cultured at 21 % oxygen tension; $ or $$$ indicates
significant comparisons between untreated and cytokine-treated
constructs cultured at 5 % oxygen tension; ** or *** indicates
significant comparisons between TNFa and TNFa ? L-NIO
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100 ng/ml of TNFa. At the highest cytokine concentration
(100 ng/ml), the inhibitory effect on GAG synthesis was
greater at 5 % oxygen when compared to 21 % (p\ 0.01).
In the absence of the cytokine, GAG loss was inhibited with
L-NIO at both 5 and 21 % oxygen (p\ 0.01 and p\ 0.001,
respectively; Fig. 2b). At TNFa concentrations of
10–100 ng/ml, the cytokine increased GAG loss (p\ 0.05),
and this response was reversed with the NOS inhibitor. At
100 ng/ml TNFa, the increase in GAG loss was greater at
5 % oxygen when compared to 21 % (p\ 0.01).
Dynamic compression reduced TNFa induced
catabolic effects at 5 and 21 % oxygen
Figure 3 reveals that in the absence of the cytokine,
dynamic compression did not significantly influence NO
release at either 5 or 21 % oxygen tension. In unstrained
constructs, TNFa enhanced NO production with a greater
effect at 5 % oxygen (41.6 lM) when compared to 21 %
oxygen (28.5 lM), and the response was reduced with
dynamic compression (all p\ 0.001; Fig. 3a, b). The
magnitude of inhibition was greater at 5 than 21 % oxygen,
as indicated in Table 1, and the inhibitory effect abolished
with L-NIO (p\ 0.001).
In the absence of the cytokine, dynamic compression did
not significantly influence PGE2 release at either oxygen
tension (Fig. 3c, d). In unstrained constructs, TNFa
increased PGE2 release when compared to untreated
controls (p\ 0.001), with values greater at 5 %
(1517.5 pg/ml) than 21 % (795.1 pg/ml) oxygen tension.
Stimulation with either dynamic compression or the NOS
inhibitor reduced cytokine-induced PGE2 release (all
p\ 0.001) with the magnitude of inhibition greater at 5 %
than 21 % oxygen tension (Table 1). Co-stimulation with
both compression and the NOS inhibitor induced a further
reduction in PGE2 release (all p\ 0.001) with the mag-
nitude of inhibition greater at 5 % than 21 % (Table 1).
In the absence of the cytokine, dynamic compression did
not significantly influence MMP activity at either oxygen
tension (Fig. 3e, f). In unstrained constructs, the cytokine
increased MMP activity when compared to untreated
controls (p\ 0.001), with values marginally greater at 5 %
than 21 % oxygen (p\ 0.001). Stimulation with dynamic
compression or the NOS inhibitor reduced cytokine-in-
duced MMP activity (all p\ 0.001) with the magnitude of
inhibition greater at 5 % than 21 % oxygen (Table 1). In
the presence of TNFa, co-stimulation with compression
and L-NIO reduced MMP activity (all p\ 0.001) with the
magnitude of inhibition broadly similar at both oxygen
tensions (Table 1).
Dynamic compression reversed TNFa-induced GAG
synthesis at 5 and 21 % oxygen
GAG synthesis was enhanced by dynamic compression
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Fig. 3 The effects of TNFa and dynamic compression on the
production of catabolic mediators at 5 and 21 % oxygen tension.
Chondrocyte/agarose constructs were subjected to dynamic compres-
sion (15 %, 1 Hz) in the presence or absence of TNFa (0 or 10 ng/ml)
and/or L-NIO (1 mM) for 48 h and the effects of 5 and 21 % oxygen
were examined on NO release (a, b), PGE2 release (c, d) and total
MMP activity (e, f). Error bars represent the mean and SEM values
for 8–12 replicates from four separate experiments. *, ** or ***
indicates significant comparisons between the different treatment
conditions. All other comparisons were not significant (not indicated)
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Fig. 4) with a greater magnitude in stimulation for con-
structs cultured at 21 % oxygen than 5 % (Table 1). At
both oxygen tensions, TNFa reduced GAG synthesis (all
p\ 0.01; Fig. 4a, b). Dynamic compression increased
GAG synthesis in cytokine-treated constructs (both
p\ 0.001), with the magnitude of stimulation greater at
21 % oxygen than 5 %. Co-stimulation with dynamic
compression and L-NIO increased GAG synthesis
(p\ 0.001, Fig. 4a, b) with the magnitude of stimulation
by dynamic compression greater at 5 % oxygen than 21 %
(90.9 vs 64.5 %, respectively). GAG loss was not
influenced by compression at either oxygen tension
(Fig. 4a, b, inset).
Low oxygen tension increased expression of MMP-
13 and ADAMTS-5 in chondrocytes treated
with TNFa and the response was reduced
by dynamic compression
We examined whether oxygen tension influenced gene
expression of MMP-13 and ADAMTS-5 in chondrocytes
cultured with TNFa and subjected to dynamic
Table 1 The effects of oxygen tension and dynamic compression on catabolic/remodelling activities in chondrocyte/agarose constructs treated
with TNFa
NO release PGE2 release MMP activity GAG synthesis
21 % 5 % 21 % 5 % 21 % 5 % 21 % 5 %
Untreated -20.6 (±4.4) -19.9 (±8.3) -20.8 (±4.7) -17.0 (±7.6) -16.1 (±4.9) -34.4 (±7.3) 47.9 (±3.1) 32.9 (±5.5)
TNFa -39.9 (±2.1) -50.7 (±2.1) -43.8 (±3.3) -60.3 (±4.8) -43.8 (±6.6) -67.1 (±5.1) 106.7 (±24.2) 82.3 (±7.2)
TNFa ? L-NIO -45.3 (±8.9) -47.6 (±14.6) -66.2 (±2.6) -79.9 (±2.5) -66.2 (±7.3) -38.1 (±5.9) 64.4 (±2.9) 90.9 (±5.9)
Chondrocyte/agarose constructs were subjected to dynamic compression in the presence and absence of TNFa and/or L-NIO at 5 and 21 %
oxygen tension for 48 h. Values were expressed as a percentage change from unstrained control samples (%) where numbers in brackets
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Fig. 4 The effects of TNFa and
dynamic compression on GAG
synthesis and loss in constructs
cultured at 5 and 21 % oxygen.
Chondrocyte/agarose constructs
were subjected to dynamic
compression (15 %, 1 Hz) in
the presence or absence of
TNFa (0 or 10 ng/ml) and/or
L-NIO (1 mM) at 5 and 21 %
oxygen tension for 48 h where
GAG synthesis (a, b) and GAG
loss (inset). Error bars represent
the mean and SEM values for 8
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compression. At 5 and 21 % oxygen tensions, the presence
of TNFa increased gene expression of MMP-13 and
ADAMTS-5 when compared to untreated controls (both
p\ 0.001; Fig. 5). In unstrained constructs, we observed
greater levels of MMP-13 (p\ 0.05) and ADAMTS-5
(p\ 0.01) gene expression at 5 % oxygen tension than
21 % oxygen tension. The induction of MMP-13 and
ADAMTS-5 gene expression by TNFa at 5 and 21 %
oxygen tension were reduced with the NOS inhibitor or
abolished by stimulation with dynamic compression.
Discussion
TNFa is well known to stimulate production of catabolic
mediators such as NO and PGE2 which inhibit matrix
synthesis and induce cartilage degradation [7, 15–22]. The
in vitro studies correlate with previous animal studies
which showed that selective inhibition of iNOS reduced the
symptoms of inflammation and biomechanical abnormali-
ties in osteoarthritic joints [38–40]. However, the
overproduction of cytokines in response to oxygen tension
and the effect of biomechanical signals on the cell sig-
nalling process is less clear. Indeed, the levels of oxygen
tension in the diseased joint will have a significant impact
on metabolic processes, with the potential to trigger path-
ways induced by TNFa. The interactions between
cytokines, oxygen tension and mechanical loading are
therefore complex and require further investigation.
In ex vivo studies, we observed dose-dependent
increases in NO, PGE2 and MMPs, that was paralleled with
an inhibition of matrix synthesis and loss at the highest
cytokine concentration. Reduced oxygen tension at 5 %
was observed to enhance the effects induced by TNFa with
greater induction of MMP-13 and ADAMTS-5 gene
expression and levels of NO, PGE2 and MMP activity that
also favours the inhibition of matrix synthesis and loss. In a
previous study, bovine chondrocytes stimulated with IL-1b
in suspension culture exhibited a similar response, with
greater levels of NO and PGE2 production at 5 % when
compared to 21 % oxygen tension [30]. The enhanced
production of NO under hypoxic conditions can contribute
to the production of reactive oxygen species (ROS) that
amplifies the catabolic response [12]. Furthermore, the p55
TNFa receptor is highly expressed in human chondrocytes
from OA cartilage and is particularly susceptible to
degradative stimuli [41]. Activation of p55 by TNFa was
shown to increase synthesis of NO, PGE2, MMPs and
cytokines such as IL-6, IL-8 that degrade collagen type II,
IX and XI and inhibit matrix synthesis in a concentration-
dependent manner [20–22, 42–44]. However, studies on
the effect of low oxygen tension in chondrocytes have
resulted in conflicting outcomes. Porcine explants treated
with IL-1a or TNFa increased levels of NO and PGE2
under normoxic conditions (21 %) when compared to
severe hypoxic conditions (1 %) [31]. In contrast, cyto-
kine-treated chondrocytes induced a reduction in oxidative
stress resulting in reduced MMP-9 levels at moderate
hypoxia (6 %) when compared to normoxia (21 %) and
stablization of hypoxia-inducible factor-1a (HIF-1a)
expression [32]. Indeed, the regulation of HIF-1a by oxy-
gen tension may present a potential target for OA therapy,
since HIF-1a over-expression in OA chondrocytes is
known to have detrimental effects in cartilage pathophys-
iology. Furthermore, factors involved in the NFjb and
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Fig. 5 The effects of TNFa and dynamic compression on MMP-13
and ADAMTS-5 gene expression at 5 and 21 % oxygen. Chondro-
cyte/agarose constructs were subjected to dynamic compression
(15 %, 1 Hz) in the presence or absence of TNFa (0 or 10 ng/ml) and/
or L-NIO (1 mM) at 5 and 21 % oxygen tension for 48 h where
MMP-13 (a) and ADAMT-S5 (b) gene expression. Error bars
represent the mean and SEM values for 6 replicates from two separate
experiments. *** indicates significant comparisons between the
different treatment conditions. All other comparisons were not
significant (not indicated)
Oxygen tension modulates the effects of TNFa in compressed chondrocytes 55
123
induced by the cytokine at 5 % oxygen tension, presenting
supplementary oxygen-sensitive mediators as potential
therapeutic targets for treating OA [30, 33]. Collectively,
these studies emphasize the oxygen-dependency of the pro-
inflammatory induced effects in chondrocytes and suggest
that further studies should examine the interplay of the
cytokine-induced pathways with oxygen tension.
In ex vivo bioreactor studies, dynamic compression
reduced the production of inflammatory mediators in
response to TNFa, and this response was abolished when
dynamic compression was coupled with the NOS inhibitor.
We observed differences in the loading-induced response
such that the magnitude of inhibition was greater at 5 %
oxygen tension than 21 %. In addition, the beneficial
response was paralleled with anabolic activities as typified
by increased matrix synthesis, that was greater at 21 %
oxygen tension than 5 %. The literature is sparse with
respect to the combined effect of TNFa and dynamic
compression at low oxygen tensions in chondrocytes.
However, the effect of oxygen tension and mechanical stress
is well characterized [11, 44, 45]. Matrix synthesis was
increased and chondrogenic gene expression was stabilized
by long-term mechanical loading at 5 % oxygen tension
when compared to 21 % in a chondrocyte/polyurethane
model [45]. A similar effect was observed in the alginate
model which reported a greater production of GAG syn-
thesis at 5 % oxygen tension compared to 20 % [46]. The
differences observed in the present study are due to the type
of model system used, e.g. cell type, 2D vs 3D model, pri-
mary vs passage cells, free-swelling culture vs mechanical
loading, uninterrupted oxygen tension using the biospherix
system vs oxygen controlled incubators [47, 48]. Conversely
in porcine cartilage explants, mechanical loading enhanced
NO production at 5 and 20 % oxygen tension and the
response was reduced at 1 % oxygen tension [11, 44].
However, the manner in which cytokine-induced inflam-
matory pathways are influenced by oxygen tension and
biomechanical signals are unclear. Further studies are nee-
ded to unravel the distinct pathways induced by oxygen
tension, biomechanical signals and TNFa. This will help to
identify key targets and potential therapies for OA.
In summary, the present study demonstrates that
exogenous TNFa combined with low oxygen tension
enhanced the production of NO, PGE2 and MMPs. The
effects of TNFa were reduced with biomechanical signals
or the presence of the NOS inhibitor in an oxygen-depen-
dent manner, leading to restoration of matrix synthesis.
Although selective inhibition of NOS and stimulation with
biomechanical signals is chondroprotective, further studies
are needed to unravel the distinct pathways induced by
oxygen tension, biomechanical signals and TNFa. This will
help to identify key targets and potential therapies for OA
treatments.
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